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Previews
hosts versus those that do not carry the marker of boneReenthronement of the
marrow origin.Muscle Satellite Cell The upshot is that a single population is identified as
substantially myogenic according to the criteria applied:
namely spontaneous differentiation in tissue culture, ex-
pression of muscle-specific genes on coculture with
In this issue of Cell (Sherwood et al., 2004), a quantita- myogenic cells, and participation in myogenesis on
tive survey confirms that repair of skeletal muscle is transplantation into regenerating muscle. This popula-
overwhelmingly attributable to the endogenous satel- tion is a subset of the fiber-associated cell that does
lite cell population but that experience of a regenerat- not carry the GFP bone marrow marker and is thus of
ing muscle environment confers some myogenic qual- endogenous muscle origin. These cells belong to the
ities onto a tiny population of bone marrow-derived sorted subset that are CD34Sca1, a phenotype that
cells. corresponds well to the preactivated satellite cell on
isolated muscle fibers (Zammit and Beauchamp, 2001).
The other major fiber associated population, CD34Viewed historically, skeletal muscle would appear an
Sca1, forms fibroblast-like colonies in culture and doesunlikely arena for the debate on stem cell plasticity.
not contribute to muscle regeneration in vivo, corre-From its discovery in 1961, the satellite cell, nestling
sponding phenotypically to the microvessel associatedbetween the fiber surface and the overlying basement
cells (Zammit and Beauchamp, 2001)membrane, has been the almost uncontested candidate
In line with previous studies using transgene-markedas the muscle precursor or tissue specific stem cell. It
bone marrow, cells of bone marrow origin are found inhas remained so until recent challenge of its status by
both fiber-associated and interstitial categories ex-a string of demonstrations that cells derived from geneti-
tracted from either regenerating or nonregeneratingcally marked bone marrow grafts can contribute to re-
muscle. However, these two environments exert theirgenerating skeletal muscle (Ferrari et al., 1998; Gussoni
own distinct effects on the behavior of the bone marrow-et al., 1999; LaBarge and Blau, 2002). That this has
derived cells that take up residence within them. In bothdeveloped into a lively debate, punctuated by minor
cases, populations are found bearing a range of anti-skirmishes, has more to do with differences in interpreta-
genic profiles, including some corresponding to thosetion and emphasis than with truly discrepant results
found on resident GFP cells, but the functional charac-between the proponents of the various schools of
teristics of these cells differ according to whether or notthought. Now, a paper by Sherwood et al. (2004) cuts a
the muscle had been injured. GFP cells from noninjuredswathe through the main areas of altercation, effectively
muscles showed little or no myogenic function by any ofreinstating the satellite cell as the main player in the
the tests, whereas cells from the same sorting windows,
mechanism of regeneration of skeletal muscle and re-
derived from muscles injured two days previously, were
ducing the issue from grand arguments over fundamen-
found to show minor but distinct propensities for some
tal biological principles to quibbles over minor issues. degree of myogenic differentiation by one or more of
It does however redeem some of the grounds for argu- the test criteria. Whether this change is generated by
ment and further investigation by identifying some fasci- an educational process or by selection of cells with such
nating features of the routes by which the occasional competence from the general bone marrow-derived
bone marrow-derived cell finds its way into the regener- population within regenerating muscle is clearly of inter-
ating muscle fiber. In addition, it raises new questions est. Intriguingly, such cells are generated within animals
about recent proposals of a resident muscle stem cell grafted with whole bone marrow but not with hematopoi-
situated outside the classical satellite cell compartment. etic stem cells. This functional change is not restricted
Telling findings are based mainly on a two-phase en- to simple ability to express muscle genes and to become
zymic digestion of whole muscle, resulting in segrega- involved in muscle regeneration if injected into a dam-
tion into the readily dissociated “interstitial” cells and aged muscle, for the fiber-associated cells showed a
the “fiber-associated” cells released during the second predilection to reenter this compartment on reinjection
phase. This protocol has the virtue of providing cells in into such a muscle.
sufficient numbers for a range of analytical and prepara- At the time of its discovery, the fact that circulating
tive FACS sorts on the basis of antigenic and lineage bone marrow-derived cells could contribute to various
markers. This permits a degree of quantitative compari- tissues, including skeletal muscle, generated consider-
son between cell populations with the result that some able excitement because both of its therapeutic promise
perspective can be put on the relative importance of and its fundamental biological implications. It held hope
the functional groups described. Its main limitation is of fulfilling the would-be cell therapist’s dream of dis-
that the two main populations cannot be linked precisely persed distribution of multipotent cells from a bone-
to any histologically defined cell compartment. In prac- marrow reservoir to sites of muscle repair (Partridge,
tice, this presents no major impediment to broad inter- 2003). It was also suggested that delivery via the blood
pretation and a number of clear points emerge from this vascular route might be a significant arm of the mecha-
study, notably in the analysis of the activities of cells nism of normal maintenance of tissue-specific precur-
sors, constituting the “stem cell highway” (Blau et al.,from GFP-marked bone marrow in non-GFP transgenic
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2001). This ran counter to earlier findings based on a HDAC4: A Corepressor Controlling
less sensitive marker (Grounds, 1983) and is flatly con- Bone Developmenttradicted by the Sherwood study, but the sporadic entry
of cells derived from whole bone marrow grafts into the
myogenic process, seemingly by a number of pathways,
is vindicated, and sustains some hope of therapeutic RUNX2 is a transcription factor with a well-character-
applicability. This study also failed to confirm the thesis ized role in bone development. In this issue of Cell,
that CD45 cells residing in muscle act as a significant Vega and colleagues (Vega et al., 2004) show that
source of myogenic stem cells, (Polesskaya et al., 2003) HDAC4 interacts with RUNX2 and impacts upon chon-
but the original claim was made on the basis of a four drocyte hypertrophy and bone formation.
day postinjury model rather than the two day setup used
here, and one should be wary of the transience of ex- Histone deacetylases (HDACs) are transcriptional coreg-
pression of some of the markers used in the majority of ulators with the capability of modifying chromatin struc-
these studies. Doubt as to the applicability of general ture and other transcription factors. HDACs fall into two
principles between species must also be born in mind, general classes based on sequence homology and do-
especially in view of the recent description of what ap- main structure. Class I HDACs have homology to yeast
pears to be a robust myogenic activity in vivo among a RPD3 and lack an N-terminal domain present in class
tiny minority population of circulating cells in human II proteins. Class II HDACs are homologous to yeast
blood (Torrente et al., 2004). HDA1 and have an N-terminal extension that regulates
Undoubtedly, the main impact of the Sherwood paper activity. HDACs are emerging in vital cellular processes
is to consolidate the view that the contribution of cells including growth, differentiation, and apoptosis, among
derived from the bone marrow into regenerating skeletal others. They are of interest as pharmacological targets
muscle under normal physiological circumstances is in cancer and in cardiac pathology. Because of their
trivial. Although it does not completely invalidate the widespread importance and enormous clinical potential,
notion of therapeutic application of this mechanism, it a clear understanding of their functions in vivo is urgent.
certainly provides no encouragement. However, the fact The Olson laboratory has made dedicated efforts to
that some bone marrow cells can be persuaded into the characterizing the class II HDACs. Recently, they dem-
myogenic pathway remains as a tantalizing conundrum. onstrated a critical role in modulating the growth re-
What is the nature of this phenomenon? In itself, it is too sponse of cardiac muscle to work (Chang et al., 2004;
ineffectual to be selectable by Darwinian mechanisms. Zhang et al., 2002). Loss-of-function in HDAC5 or
Could it be an ancillary of some more biologically impor- HDAC9 results in cardiac hypertrophy in unchallenged
tant process or is it simple biological “noise” within the mice, and the deficiencies cause hypersensitivity to car-
mechanisms of differentiation? diac stress such as banding of the thoracic aorta or
ectopic expression of calcineurin. Conversely, a gain-
of-function mutation in a product of the HDAC9 gene
Terence Partridge inhibits cardiomyocyte hypertrophy in vitro. The pheno-
Muscle Cell Biology Group typic effects of the class II HDACs are, at least in part,
MRC Clinical Sciences Centre associated with MEF2, a transcription factor connected
Du Cane Road with cardiac hypertrophy. Thus, two class II HDACs have
London, W12 0NN in vivo roles in a pathway controlling cardiac cell growth,
United Kingdom and their activity is mediated by a key DNA binding
transcription factor.
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